Clinical Trials on STD in Finland
I alt 1890 resultater
-
University of OuluAfsluttetSæsonbestemt affektiv lidelse (SAD)Finland
-
Turku University HospitalNordic Urothelial Cancer GroupRekruttering
-
Turku University HospitalNordic Urothelial Cancer GroupRekrutteringBlærekræft | Invasiv blærekræftFinland
-
Turku University HospitalNordic Urothelial Cancer GroupRekruttering
-
Turku University HospitalUkendt
-
Turku University HospitalRekruttering
-
Turku University HospitalRekrutteringProstatakræft | Lokaliseret prostatakarcinom | Mellemrisiko prostatakræft | Kastrationsnaiv prostatakræftFinland
-
Helsinki University Central HospitalFinnish Foundation for Cardiovascular Research; Aarne Koskelo FoundationAfsluttet
-
Turku University HospitalAfsluttet
-
Finnish Breast Cancer GroupAfsluttet
-
AstraZenecaAfsluttetGefitinib (Iressa) in Combo With Chemoradiation in Patients With Locally Advanced Head & Neck CancerNeoplasmer i hoved og halsFinland
-
Finnish Breast Cancer GroupSanofi; Hoffmann-La Roche; AstraZenecaAfsluttet
-
Helsinki University Central HospitalAktiv, ikke rekrutterende
-
Tampere University HospitalTurku University Hospital; Oulu University HospitalAfsluttet
-
Turku University HospitalRekruttering
-
Boneca CorporationAfsluttetHoved- og halskræftFinland
-
University of JyvaskylaHelsinki University Central HospitalAfsluttet
-
Tampere UniversitySuspenderet
-
Boneca CorporationAfsluttet
-
University of OuluOulu University HospitalAfsluttetUrogenitale neoplasmer | Neoplasmer efter sted | Genitale neoplasmer, mandlige | Prostatiske neoplasmerFinland
-
Blue Earth DiagnosticsAfsluttet
-
Lidds ABAfsluttet
-
University of OuluOulu University HospitalAfsluttet
-
Tampere UniversityAfsluttet
-
Helsinki University Central HospitalAktiv, ikke rekrutterende
-
Turku University HospitalAfsluttet
-
AstraZenecaAfsluttet
-
University of OuluOulu University HospitalAfsluttetProstatiske neoplasmerFinland
-
Tampere University HospitalAfsluttetProstatisk neoplasma | AnastomoseFinland
-
Turku University HospitalRekruttering
-
Tampere University HospitalSeinajoki Central HospitalAktiv, ikke rekrutterende
-
Turku University HospitalUniversity of TurkuAfsluttet
-
AstraZenecaAfsluttetIkke-metastatisk prostatakræftFinland
-
AstraZenecaAfsluttetSubjects With Resectable Local or Locally Advanced, Non-Metastatic (T2-T4, N0-N3, M0; Stages II and III) and Histologically-Confirmed Intestinal GCFinland
-
Tampere University HospitalTurku University Hospital; Helsinki University Central Hospital; Kuopio University... og andre samarbejdspartnereAfsluttetMetastatisk prostatakræftFinland
-
Kuopio University HospitalUkendt
-
Tampere University HospitalHelsinki University Central Hospital; Tampere University; University of Eastern... og andre samarbejdspartnereAktiv, ikke rekrutterende
-
Tampere University HospitalAfsluttet
-
Tampere University HospitalVaralan urheiluopistoUkendt
-
Turku University HospitalAfsluttetKolorektal cancerFinland
-
Tampere UniversityFinnish Prostate Cancer GroupUkendtPatienter med T1-4 avanceret prostatakræftFinland
-
Pia OsterlundRekrutteringMetastatisk tyktarmskræftFinland
-
University of HelsinkiHelsinki University Central HospitalUkendt
-
Pia OsterlundRekrutteringMetastatisk tyktarmskræftFinland
-
Turku University HospitalUkendt
-
Turku University HospitalUniversity of TurkuAfsluttetHøjrisiko prostatakræftFinland
-
Turku University HospitalGE Healthcare; Blue Earth DiagnosticsAfsluttet
-
Injeq LtdAfsluttet